Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) Clinical Trials

Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)

Explore clinical trials studying Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type) trial results

Completed

Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma

NCT01556035

Conditions: Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
Locations: CHU Amiens, Hôpital Sud Amiens, France

CHU Besançon, Hôpital Saint-Jacques Besançon, France

AP-HP Hôpital Avicenne Bobigny, France

AP-HP Hôpital Ambroise Paré Boulogne-Billancourt, France

View all 24 locations

View Trial Details